Skip to content
Chemular Logo Chemular Logo Chemular Logo
  • Regulatory Consulting
  • Active Ingredients
  • Tax Compliance
  • About Us
  • Resources
    • News & Press
    • Insights
    • Events & Publications
      • TSRC 2021
      • TSRC 2022
      • TSRC 2023
      • TSRC 2024
      • TSRC 2025
      • TSRC 2026
      • TPE 2024
      • FDLI 2024
  • Contact Us
  • All Events
  • TSRC 2026
  • TSRC 2025
  • TSRC 2024
  • TPE 2024
  • TSRC 2023
  • TSRC 2022
  • TSRC 2021

  • TSRC 2026

    Evaluation of the Abuse Liability of Nic Nac Tobacco-Free Nicotine Lozenges Compared With Usual-Brand Cigarettes

  • TSRC 2026

    THE IMPORTANCE OF USER SURVEYS IN ASSESSING TOBACCO PRODUCT USE PATTERNS TO INFORM REGULATORY DECISION MAKING

  • TSRC 2026

    NOMINAL NICOTINE STRENGTH IS AN UNRELIABLE PREDICTOR OF ABUSE LIABILITY FOR NICOTINE POUCHES

  • TSRC 2026

    IN VITRO TOXICOLOGICAL ASSESSMENT OF NIC NAC ORAL NICOTINE LOZENGE PRODUCTS

  • TSRC 2026

    HPHC ANALYSIS OF NIC NAC ORAL NICOTINE LOZENGE PRODUCTS

  • TSRC 2026

    CANADIAN NHP BIOCOMPATIBILITY ASSESSMENT OF NEO 4 mg ORAL NICOTINE POUCH

12Next

Quick Links

  • News & Press
  • Regulatory Consulting
  • Active Ingredients
  • Innovation
  • Events

About Us

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Use

Get In Touch

[fusion_form form_post_id=”6280″ hide_on_mobile=”small-visibility,medium-visibility,large-visibility” margin_top=”-10px” /]

© Copyright 2012 – 2025 | Chemular Inc.

Page load link
Go to Top